Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ocular Graft vs Host Disease”

73 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 73 results

Testing effectiveness (Phase 2)Study completedNCT03298815
What this trial is testing

Study for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED)

Who this might be right for
Ocular Graft Versus Host Disease
University of Utah 15
Testing effectiveness (Phase 2)Study completedNCT05311514
What this trial is testing

Allogeneic Platelet Lysate Eye Drops for the Treatment of Severe Chronic Ocular Graft-versus-host Disease

Who this might be right for
Ocular Graft-versus-host Disease
St. Petersburg State Pavlov Medical University 38
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Not applicableEnded earlyNCT00842413
What this trial is testing

Investigating the Role of the Premotor Cortex in Higher Cognitive Functions

Who this might be right for
Brain InjuryChronic
Assistance Publique - Hôpitaux de Paris 9
Testing effectiveness (Phase 2)Ended earlyNCT02702518
What this trial is testing

RhDNase Eye Drops in Patients With Ocular Graft-Vs.-Host Disease

Who this might be right for
Ocular Graft vs Host DiseaseDry Eye
University of Illinois at Chicago 58
Not applicableStudy completedNCT02066051
What this trial is testing

IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD

Who this might be right for
GVHDOcular RosaceaDry Eye Syndrome
Mayo Clinic 8
Not applicableStudy completedNCT02712762
What this trial is testing

Ocular Surface Disease in Chronic Graft-Versus-Host Disease (GVHD) Patients

Who this might be right for
Dry EyeGVHD
Singapore National Eye Centre 5
Not applicableUnknownNCT03731624
What this trial is testing

Diadenosine Polyphosphates and Mucin Associated With Ocular Surface Disorders

Who this might be right for
Superior Limbic KeratoconjunctivitisDry Eye SyndromesGraft Vs Host Disease
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation 50
Not applicableUnknownNCT00006056
What this trial is testing

Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders

Who this might be right for
Chediak-Higashi SyndromeGraft Versus Host DiseaseX-Linked Lymphoproliferative Syndrome+3 more
Fairview University Medical Center 40
Not applicableStudy completedNCT07066865
What this trial is testing

Evaluation of the Safety and Effectiveness of omniLenz in Patient With Ocular Graft vs Host Disease

Who this might be right for
Ocular Graft Versus Host Disease
Farwaniya Hospital 3
Testing effectiveness (Phase 2)Study completedNCT00089011
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more
Fred Hutchinson Cancer Center 150
Not applicableUnknownNCT03064984
What this trial is testing

Blood Based Eyedrops From Different Sources in the Treatment of Severe Keratopathy

Who this might be right for
KeratopathySjogren's SyndromeGVHD - Graft-Versus-Host Disease
IRCCS Azienda Ospedaliero-Universitaria di Bologna 60
Not applicableStudy completedNCT01234623
What this trial is testing

Cord Blood Serum in the Treatment of Ocular Surface Diseases

Who this might be right for
Graft vs Host DiseaseSjogren's Disease
IRCCS Azienda Ospedaliero-Universitaria di Bologna 30
Not applicableLooking for participantsNCT07166848
What this trial is testing

Electrostimulation Study for Ocular Graft vs. Host Disease

Who this might be right for
Chronic Ocular Graft-versus-host Disease
Zhonghui K. Luo, MD, PhD 15
Not applicableStudy completedNCT02945176
What this trial is testing

Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation

Who this might be right for
Graft vs Host DiseaseCongenital AniridiaChemical Burns+2 more
Implandata Ophthalmic Products GmbH 13
Very early researchStudy completedNCT04792580
What this trial is testing

The Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Subjects With Dry Eye Disease in Ocular Graft-versus-Host Disease

Who this might be right for
Graft-versus-host-diseaseOcular Graft-versus-host Disease
Richard W Yee, MD 30
Testing effectiveness (Phase 2)Study completedNCT03990051
What this trial is testing

Treatment Safety and Efficacy of Pro-ocular™ 1% for Chronic Ocular Graft Following Allogeneic HSCT.

Who this might be right for
Chronic Ocular Graft-versus-host Disease
Glia, LLC 33
Post-approval studies (Phase 4)UnknownNCT04636918
What this trial is testing

Ikervis for DED Due to GVHD Post Allo-HSCT

Who this might be right for
Leukemia (Both ALL and AML)MDS-EB-1
Singapore Eye Research Institute 40
Not applicableStudy completedNCT04793230
What this trial is testing

Nasolacrimal Sac Biopsy in Endoscopic Dacryocystorhinostomy

Who this might be right for
Dacryocystitis; Chronic
Al-Azhar University 50
Testing effectiveness (Phase 2)Looking for participantsNCT07118254
What this trial is testing

A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CROSSOVER STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 μG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)

Who this might be right for
Ocular Graft Versus Host Disease
Lubris Bio Pty Ltd 15
Load More Results